Central serous chorioretinopathy associated with administration of sympathomimetic agents

John C. Michael, John Pak, Jose Pulido, Guillermo De Venecia

Research output: Contribution to journalArticlepeer-review

55 Scopus citations


PURPOSE: To report central serous chorioretinopathy associated with excessive use of compounds with sympathomimetic activity. DESIGN: Observational case series. METHODS: Four patients presented with clinical and fluorescein angiographic evidence of central serous chorioretinopathy. All patients expressed a concomitant psychogenic stress and high-dose ingestion of pseudoephedrine, oxymetazoline, or 3,4-methylenedioxymethamphetamine, all of which possess sympathomimetic properties. RESULTS: In all cases, resolution of central serous chorioretinopathy coincided with cessation of the medication. CONCLUSIONS: Patients afflicted with central serous chorioretinopathy should be notified about its possible association with sympathomimetic medications.

Original languageEnglish (US)
Pages (from-to)182-185
Number of pages4
JournalAmerican journal of ophthalmology
Issue number1
StatePublished - Jul 1 2003

ASJC Scopus subject areas

  • Ophthalmology


Dive into the research topics of 'Central serous chorioretinopathy associated with administration of sympathomimetic agents'. Together they form a unique fingerprint.

Cite this